arrow
M

Marcela Del Río

centro de investigación biomédica en red de enfermedades raras
H指数:44
被引数:5,986

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

A Mechanistic Map of the Phenotypic Complexity in Recessive Dystrophic Epidermolysis Bullosa Provides Basis for Therapeutic Target Discovery and Drug Repurposing

隐性营养不良性大疱性表皮松解症的表型复杂性机制图谱为治疗靶点发现和药物重定位提供了基础

2026-09-220
OA
MesenSistem-EB: systemic haploidentical mesenchymal stem cell therapy in recessive dystrophic epidermolysis bullosa associated with clinical benefits and correlated with MCP1 and sCD40L dynamics

MesenSistem-EB:系统性单倍型间充质干细胞疗法在常染色体隐性营养不良性大疱性表皮松解症中的应用,与临床益处相关,并与MCP1和sCD40L动态变化相关

2026-05-050
OA
Zinc as a Biomarker of Nutritional Status and Clinical Burden in Recessive Dystrophic Epidermolysis Bullosa: Implications for Preventive Monitoring

锌作为隐性营养不良性大疱性表皮松解症的营齤状况和临床负担的生物标志物:对预防性监测的启示

2026-01-140
OAAI
Base edited skin equivalents with clinical potential for ex vivo correction of Recessive Dystrophic Epidermolysis Bullosa

具有临床潜力的碱基编辑皮肤替代物,用于体外修复隐性营养不良型大疱性表皮松解症

2025-11-170
PRE
Safe and Efficacious Permanent Removal of Large COL7A1 Exons for Gene Reframing as a Reliable Therapeutic Strategy for Recessive Dystrophic Epidermolysis Bullosa

安全且有效的永久性移除大型COL7A1外显子以实现基因重构,作为一种治疗隐性营养不良性大疱性表皮松解症的可靠治疗策略。

2025-05-280
PRE
Unveiling the value of C-reactive protein as a severity biomarker and the IL4/IL13 pathway as a therapeutic target in recessive dystrophic epidermolysis bullosa: A multiparametric cross-sectional study
2024-07-291
OAAI
Gluten-sensitive enteropathy in recessive dystrophic epidermolysis bullosa
2023-09-010
PRE
Evaluation of Systemic Gentamicin as Translational Readthrough Therapy for a Patient With Epidermolysis Bullosa Simplex With Muscular Dystrophy Owing to PLEC1 Pathogenic Nonsense Variants
2022-04-0111
OA
Beneficial Effect of Systemic Allogeneic Adipose Derived Mesenchymal Cells on the Clinical, Inflammatory and Immunologic Status of a Patient With Recessive Dystrophic Epidermolysis Bullosa: A Case Report
2020-11-2611
OAAI